Literature DB >> 28496927

E/Ea For The Prediction of Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation and Severe Mitral Stenosis.

Atoosheh Rohani1, Hoorak Poorzand1, Mohammad R Arefifar1.   

Abstract

Atrial fibrillation (AF), left atrial appendage thrombi (LAAT) and subsequent embolic stroke are the most frequent complications of mitral stenosis .E/Ea is used traditionally for the assessment of left atrium pressure, and besides AF and dilated LA size which promotes stasis of blood in LA, high LA pressure also play a role to clot formation in LA .The receiver operator characteristics (ROC) curve point-coordinates identified an E:e' value of ≥ 36.5to have 57.14% sensitivity and 90.91% specificity for LAAT;We find this ratio relatively specific for prediction of LAAT, independent of MVA and LA volume, however it needs to be externally validated.

Entities:  

Keywords:  Atrial Fibrillation; Left Atrial Appendage Thrombi; Mitral Stenosis

Year:  2016        PMID: 28496927      PMCID: PMC5368547          DOI: 10.4022/jafib.1447

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  2 in total

1.  Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Katsuomi Iwakura; Atsushi Okamura; Yasushi Koyama; Motoo Date; Yoshiharu Higuchi; Koichi Inoue; Ryusuke Kimura; Hiroyuki Nagai; Yuko Toyoshima; Makito Ozawa; Norihisa Ito; Masahiko Shibuya; Shigemiki Omiya; Takashi Takagi; Daisuke Morisawa; Kenshi Fujii
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

2.  The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Rami Doukky; Enrique Garcia-Sayan; Heather Gage; Vijaiganesh Nagarajan; Anna Demopoulos; Marek Cena; Noreen T Nazir; George J Karam; Richard G Trohman; Rasa Kazlauskaite
Journal:  Cardiovasc Ultrasound       Date:  2014-02-25       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.